Australia markets closed

Aurisco Pharmaceutical Co.,Ltd. (605116.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
24.41-0.35 (-1.41%)
At close: 03:00PM CST
Full screen
Previous close24.76
Open24.59
Bid24.41 x N/A
Ask24.42 x N/A
Day's range24.31 - 24.73
52-week range17.33 - 27.58
Volume2,458,100
Avg. volume1,787,885
Market cap9.915B
Beta (5Y monthly)-0.28
PE ratio (TTM)30.51
EPS (TTM)0.80
Earnings dateN/A
Forward dividend & yield0.16 (0.65%)
Ex-dividend date22 May 2023
1y target est31.00
  • PR Newswire

    Aurisco gets Auxiton® (Dydrogesterone) as first generic approval in China

    Aurisco Pharmaceutical has good reasons to celebrate. On its 25th anniversary, the high-tech pharmaceutical company dedicated to innovation has received its first Marketing Authorization Approval in China for AUXITON®, the oral finished dosage form of Dydrogesterone, from China's Health Authority, the NMPA. Aurisco is the only company holding both an active USDMF and a valid CEP – the Certificate of compliance with the European Pharmacopoeia, issued by the EDQM for the drug substance.